173 related articles for article (PubMed ID: 17951061)
21. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
22. N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1).
Jetter MC; McNally JJ; Youngman MA; McDonnell ME; Dubin AE; Nasser N; Zhang SP; Codd EE; Colburn RW; Stone DR; Brandt MR; Flores CM; Dax SL
Bioorg Med Chem Lett; 2008 Apr; 18(8):2730-4. PubMed ID: 18359227
[TBL] [Abstract][Full Text] [Related]
23. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
[TBL] [Abstract][Full Text] [Related]
24. Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists.
Nitta A; Iura Y; Inoue H; Sato I; Morihira K; Kubota H; Morokata T; Takeuchi M; Ohta M; Tsukamoto S; Imaoka T; Takahashi T
Bioorg Med Chem Lett; 2012 Nov; 22(22):6876-81. PubMed ID: 23046963
[TBL] [Abstract][Full Text] [Related]
25. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
[TBL] [Abstract][Full Text] [Related]
26. Novel and potent small-molecule urotensin II receptor agonists.
Lehmann F; Currier EA; Clemons B; Hansen LK; Olsson R; Hacksell U; Luthman K
Bioorg Med Chem; 2009 Jul; 17(13):4657-65. PubMed ID: 19481466
[TBL] [Abstract][Full Text] [Related]
27. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
[TBL] [Abstract][Full Text] [Related]
28. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a novel CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
[TBL] [Abstract][Full Text] [Related]
30. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
[TBL] [Abstract][Full Text] [Related]
31. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation.
Uto Y; Ogata T; Kiyotsuka Y; Miyazawa Y; Ueno Y; Kurata H; Deguchi T; Yamada M; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Konishi M; Kurikawa N; Kono K; Osumi J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4159-66. PubMed ID: 19541482
[TBL] [Abstract][Full Text] [Related]
32. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 2,5-diaminobenzamide derivatives as anti-proliferating agents.
Lee SH; Park JW; Hong JE; Park JW; Lee J
Arch Pharm Res; 2009 Jun; 32(6):803-12. PubMed ID: 19557356
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
[TBL] [Abstract][Full Text] [Related]
35. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
[TBL] [Abstract][Full Text] [Related]
36. Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitors.
Rew Y; McMinn DL; Wang Z; He X; Hungate RW; Jaen JC; Sudom A; Sun D; Tu H; Ursu S; Villemure E; Walker NP; Yan X; Ye Q; Powers JP
Bioorg Med Chem Lett; 2009 Mar; 19(6):1797-801. PubMed ID: 19217779
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of benzamide derivatives and their evaluation as antiprion agents.
Fiorino F; Eiden M; Giese A; Severino B; Esposito A; Groschup MH; Perissutti E; Magli E; Incisivo GM; Ciano A; Frecentese F; Kretzschmar HA; Wagner J; Santagada V; Caliendo G
Bioorg Med Chem; 2012 Aug; 20(16):5001-11. PubMed ID: 22795751
[TBL] [Abstract][Full Text] [Related]
38. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
Varnes JG; Gardner DS; Santella JB; Duncia JV; Estrella M; Watson PS; Clark CM; Ko SS; Welch P; Covington M; Stowell N; Wadman E; Davies P; Solomon K; Newton RC; Trainor GL; Decicco CP; Wacker DA
Bioorg Med Chem Lett; 2004 Apr; 14(7):1645-9. PubMed ID: 15026042
[TBL] [Abstract][Full Text] [Related]
39. Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.
Kriegl JM; Martyres D; Grundl MA; Anderskewitz R; Dollinger H; Rast G; Schmid B; Seither P; Tautermann CS
Bioorg Med Chem Lett; 2015 Jan; 25(2):229-35. PubMed ID: 25497216
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
